Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by McBethon Jun 13, 2008 12:26pm

765 Views

Post# 15182663

Long on ONC

I bought my first ONC @ $8.40 back in Mar/04 and have been buying small amounts since and still believe in ONC. I have recently found another very promiseing company that has a cancer treatment in clinical trials and getting postive results. Check out Kemokine Therapeutics {CTI} @ .18 I took a good size position on this one too, great potential

Bullboard Posts

Rich TV Live's Stocks to Watch this week (May 31, 2024)